Article
Extraintestinal complications of inflammatory bowel disease.
Current gastroenterology reports - 1 Dec 2003
Orchard Tim
Abstract excerpt
Recent studies of extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) have demonstrated the importance of genetic predisposition in the etiology of musculoskeletal and cutaneous manifestations. In addition, small studies have shown infliximab to be effective in treating troublesome EIMs, particularly in pyoderma gangrenosum. Other trials have examined the safety of cyclooxygenase-2-specific...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
